v3 Code System substanceAdminSubstitution
v3 Code System substanceAdminSubstitution
activeFHIR R3 package : Core3.0.2complete10 concepts
Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.
Metadata
hl7.org/fhir- Canonical URL
- http://hl7.org/fhir/v3/substanceAdminSubstitution
- ID
- v3-substanceAdminSubstitution
- Version
- 2016-11-11
- Publisher
- HL7, Inc
- Case Sensitive
- Yes
- Hierarchy
- is-a
Concepts (10)
| Code | Display | Definition |
|---|---|---|
_ActSubstanceAdminSubstitutionCode | ActSubstanceAdminSubstitutionCode | Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects. |
└E | equivalent | Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product. |
└EC | equivalent composition | Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril |
└BC | brand composition | Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven |
└G | generic composition | Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp) |
└TE | therapeutic alternative | Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet |
└TB | therapeutic brand | Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > Examples: Zantac for Tagamet |
└TG | therapeutic generic | Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > Examples: Ranitidine for cimetidine |
└F | formulary | Description: This substitution was performed or is permitted based on formulary guidelines. |
└N | none | No substitution occurred or is permitted. |